Foretinib (GSK1363089)

Foretinib (GSK1363089)

Catalog Number:
L002368457APE
Mfr. No.:
APE-A2974
Price:
$206
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          Foretinib (GSK1363089) is a novel, potent, small-molecule inhibitor of member of the vascular endothelial growth factor (VEGF)and hepatocyte growth factor (HGF) receptor tyrosine kinase families [1].
          Foretinib inhibits Met, Ron, KDR, Flt-1, Flt-4, KIT, Flt-3, Platelet-derived growth factor receptor α, Platelet-derived growth factor receptor β and Tie-2 with IC50 values of 0.4, 3, 0.86, 6.8, 2.8, 6.7, 3.6, 3.6, 9.6 and 1.1 nmol/L, respectively. Foretinib has shown to inhibit cellular MET in murine B16F10 melanoma cells and PC-3 prostate cells with IC50 values of 21 and 23 nmol/L [1].
          Foretinib revealed to inhibit the migration and invasion induced by HGF in murine B16F10 melanoma cells. Additionally, Foretinib suppressed the B16F10, A549 and HT29 tumor cells growth with IC50 values of 40, 29 and 165 nmol/L [1].

      • Properties
        • Alternative Name
          1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
          CAS Number
          849217-64-7
          Molecular Formula
          C34H34F2N4O6
          Molecular Weight
          632.65
          Appearance
          A solid
          Purity
          98.00%
          Solubility
          ≥31.65 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Shih CH, Chang YJ, et al. "EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis." Oncogene. 2017 Nov 23;36(47):6542-6554. PMID:28759046

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.